Vident Investment Advisory, LLC Myriad Genetics Inc Transaction History

Vident Investment Advisory, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$15.26 - $23.75 $213,762 - $332,690	14,008 New	14,008 $325,000
Q1 2022 May 16, 2022	SELL	$22.67 - $28.01 $167,168 - $206,545	-7,374 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $177,934 - $240,613	7,374 New	7,374 $204,000
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $200,469 - $245,218	-6,689 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $169,833 - $218,128	6,689 New	6,689 $205,000
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $3.24 Million - $4.34 Million	-86,231 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $35,880 - $51,939	1,293 Added 1.52%	86,231 $3.22 Million
Q1 2018 May 14, 2018	SELL	$28.83 - $41.01 $870,175 - $1.24 Million	-30,183 Reduced 26.22%	84,938 $2.46 Million
Q4 2017 Feb 15, 2018	BUY	$28.45 - $37.14 $199,975 - $261,057	7,029 Added 6.5%	115,121 $3.95 Million
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $2.6 Million - $3.91 Million	108,092	108,092 $3.91 Million

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.